Target intelligence / Profile preview

Valosin-containing protein (VCP)

Target
VCP
Molecular classification
AAA+ type II ATPases, Enzyme
01

Overview

Valosin-containing protein (VCP), also known as p97 or CDC48, is an AAA+ ATPase that plays a central role in the ubiquitin-proteasome system (UPS) and endoplasmic reticulum-associated degradation (ERAD). It acts as an unfoldase or segregase, using ATP hydrolysis to extract ubiquitinated substrates from complexes or membranes, facilitating their degradation by the proteasome. VCP is involved in numerous cellular processes, including cell cycle control, membrane fusion, apoptosis prevention, and DNA repair. Mutations or dysregulation in VCP are linked to several human diseases, including IBMPFD, ALS, neurodegeneration, and cardiovascular disorders.

Other names
p97CDC48TER ATPaseTransitional endoplasmic reticulum ATPase
02

Mechanism of action

ATP-dependent segregase/unfoldase using cofactors/VCP-interacting motifs (VIMs) to extract ubiquitinated substrates and deliver them to the proteasome for degradation.

03

Biological functions

Ubiquitin-proteasome system mediatorEndoplasmic reticulum-associated degradation (ERAD)Cell cycle controlMembrane fusionMembrane reassemblyApoptosis preventionDNA repairAutophagyLysosomal protein degradationLipid droplet biogenesisGolgi reassembly after mitosisMitochondrial function regulationmTOR signaling modulationS-nitrosylation promotionStress response
04

Disease associations

Inclusion body myopathy with Paget disease of bone and frontotemporal dementia (IBMPFD)Amyotrophic lateral sclerosis (ALS)Neurodegenerative diseaseCardiovascular disorders
05

Safety considerations

Inhibition may disrupt essential cellular processes.Potential for off-target effects due to broad involvement in cellular pathways.

Beyond the preview

Go deeper on Valosin-containing protein (VCP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Valosin-containing protein (VCP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call